These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 39219258)

  • 1. Drug resistance and tumor immune microenvironment: An overview of current understandings (Review).
    Liu Y; Liang J; Zhang Y; Guo Q
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39219258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?
    Sylvestre M; Tarte K; Roulois D
    Epigenomics; 2020 Jan; 12(2):157-169. PubMed ID: 31849241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment.
    Qu Y; Dou B; Tan H; Feng Y; Wang N; Wang D
    Mol Cancer; 2019 Mar; 18(1):69. PubMed ID: 30927928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
    Li S; Sheng J; Zhang D; Qin H
    Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
    Saleh R; Elkord E
    Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
    Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
    Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex interplay between tumor microenvironment and cancer therapy.
    Shen M; Kang Y
    Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.
    Maacha S; Bhat AA; Jimenez L; Raza A; Haris M; Uddin S; Grivel JC
    Mol Cancer; 2019 Mar; 18(1):55. PubMed ID: 30925923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
    Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
    Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Normalization of the Tumor Microenvironment for Cancer Therapy.
    Zheng J; Gao P
    Integr Cancer Ther; 2019; 18():1534735419862352. PubMed ID: 31282197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance.
    Li I; Nabet BY
    Mol Cancer; 2019 Mar; 18(1):32. PubMed ID: 30823926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).
    Kazakova A; Sudarskikh T; Kovalev O; Kzhyshkowska J; Larionova I
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36660926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives.
    Zahan T; Das PK; Akter SF; Habib R; Rahman MH; Karim MR; Islam F
    Anticancer Agents Med Chem; 2020; 20(18):2190-2206. PubMed ID: 32748758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.